Russell Investments Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-87,187
| Closed | -$1.52M | – | 3258 |
|
|
2020
Q4 | $1.52M | Sell |
87,187
-75,766
| -46% | -$1.06M | ﹤0.01% | 1901 |
|
|
2020
Q3 | $1.91M | Buy |
162,953
+50,936
| +45% | +$676K | ﹤0.01% | 1719 |
|
|
2020
Q2 | $1.45M | Buy |
112,017
+56,529
| +102% | +$679K | ﹤0.01% | 1832 |
|
|
2020
Q1 | $514K | Buy |
55,488
+20,579
| +59% | +$288K | ﹤0.01% | 2161 |
|
|
2019
Q4 | $578K | Buy |
34,909
+13,159
| +61% | +$213K | ﹤0.01% | 2340 |
|
|
2019
Q3 | $362K | Hold |
21,750
| – | – | ﹤0.01% | 2406 |
|
|
2019
Q2 | $299K | Sell |
21,750
-48,672
| -69% | -$744K | ﹤0.01% | 2422 |
|
|
2019
Q1 | $1.21M | Sell |
70,422
-24,515
| -26% | -$388K | ﹤0.01% | 1961 |
|
|
2018
Q4 | $1.21M | Buy |
94,937
+8,082
| +9% | +$123K | ﹤0.01% | 1847 |
|
|
2018
Q3 | $1.41M | Sell |
86,855
-10,590
| -11% | -$151K | ﹤0.01% | 1935 |
|
|
2018
Q2 | $1.26M | Buy |
97,445
+16,070
| +20% | +$217K | ﹤0.01% | 1998 |
|
|
2018
Q1 | $1.01M | Buy |
81,375
+17,850
| +28% | +$217K | ﹤0.01% | 2203 |
|
|
2017
Q4 | $901K | Sell |
63,525
-6,629
| -9% | -$97.1K | ﹤0.01% | 2201 |
|
|
2017
Q3 | $1.18M | Buy |
70,154
+1,751
| +3% | +$28.5K | ﹤0.01% | 2058 |
|
|
2017
Q2 | $1.15M | Sell |
68,403
-4,875
| -7% | -$72.9K | ﹤0.01% | 2035 |
|
|
2017
Q1 | $1.14M | Buy |
+73,278
| New | +$1.05M | ﹤0.01% | 2030 |
|
Russell Investments Group's OXFD Position: Q1 2021 in Review
Russell Investments Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 87,187 shares — an estimated $1.52M sold.
Russell Investments Group first reported a position in OXFD in Q1 2017 and held it in 16 quarters. The position peaked at $1.91M in Q3 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Russell Investments Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Russell Investments Group sold 87,187 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.52M.
- Russell Investments Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 16 quarters.
- Russell Investments Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.91M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.